- Home
- CADL vs LEO Comparison
CADL vs LEO Comparison
Compare CADL & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- LEO
- Stock Information
- Founded
- CADL 1999
- LEO 1987
- Country
- CADL United States
- LEO United States
- Employees
- CADL N/A
- LEO N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- LEO Trusts Except Educational Religious and Charitable
- Sector
- CADL Health Care
- LEO Finance
- Exchange
- CADL Nasdaq
- LEO Nasdaq
- Market Cap
- CADL 250.0M
- LEO 363.8M
- IPO Year
- CADL 2021
- LEO N/A
- Fundamental
- Price
- CADL $6.24
- LEO $5.83
- Analyst Decision
- CADL Strong Buy
- LEO
- Analyst Count
- CADL 5
- LEO 0
- Target Price
- CADL $21.40
- LEO N/A
- AVG Volume (30 Days)
- CADL 1.1M
- LEO 200.2K
- Earning Date
- CADL 08-12-2025
- LEO 01-01-0001
- Dividend Yield
- CADL N/A
- LEO 4.01%
- EPS Growth
- CADL N/A
- LEO N/A
- EPS
- CADL N/A
- LEO 0.04
- Revenue
- CADL N/A
- LEO N/A
- Revenue This Year
- CADL N/A
- LEO N/A
- Revenue Next Year
- CADL N/A
- LEO N/A
- P/E Ratio
- CADL N/A
- LEO $152.00
- Revenue Growth
- CADL N/A
- LEO N/A
- 52 Week Low
- CADL $3.79
- LEO $4.98
- 52 Week High
- CADL $14.60
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- CADL 68.08
- LEO 45.78
- Support Level
- CADL $5.78
- LEO $5.82
- Resistance Level
- CADL $6.42
- LEO $6.00
- Average True Range (ATR)
- CADL 0.36
- LEO 0.05
- MACD
- CADL 0.19
- LEO -0.00
- Stochastic Oscillator
- CADL 99.56
- LEO 27.27
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.